Stocktoria
ZEVRA THERAPEUTICS, INC. ZVRA
Nasdaq · XNAS · stock · Pharmaceutical Preparations · website · IPO 2015-04-16
ZEVRA THERAPEUTICS, INC. financials (annual, from 10-K)
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $106.5M | $23.6M | $27.5M | $10.2M | $28.6M |
| R&D expense | — | — | — | — | $10.2M |
| SG&A expense | $77.6M | $54.9M | $34.3M | $15.0M | — |
| Operating income | -$62.9M | -$87.0M | -$49.6M | -$42.6M | $7.7M |
| Interest expense | — | — | $1.5M | $335,000 | $226,000 |
| Income tax | $3.4M | $15.4M | $0 | -$33,000 | $34,000 |
| Net income | $83.2M | -$105.5M | -$46.0M | -$26.8M | -$8.6M |
| EPS (diluted) | $1.35 | $-2.28 | — | — | $-2.11 |
| Operating cash flow | -$1.6M | -$69.7M | -$33.5M | -$18.7M | $10.4M |
| Free cash flow | -$2.4M | -$69.7M | -$33.8M | -$18.8M | $10.3M |
| Cash & equivalents | $62.4M | $33.8M | $43.0M | $65.5M | $112.3M |
| Inventory | $1.7M | $2.0M | $0 | $671,000 | — |
| Total assets | $284.7M | $178.1M | $172.3M | $115.3M | $132.9M |
| Total liabilities | $130.1M | $138.5M | $110.5M | $40.2M | $5.8M |
| Shareholders' equity | $154.7M | $39.7M | $61.9M | $75.1M | $101.7M |
Source: SEC EDGAR filings · CIK 0001434647 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.